← Back to Clinical Trials
Recruiting NCT06471790

NCT06471790 Inertial Sensors for Obstetrical Walking Epidural Tracking

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06471790
Status Recruiting
Phase
Sponsor Hospices Civils de Lyon
Condition Pregnancy Related
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2024-11-11
Primary Completion 2026-07-12

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 40 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2024-11-11 with a primary completion date of 2026-07-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Freedom of movement and the ability to walk are crucial during the first stage of labor, potentially reducing labor duration, cesarean section risk, epidural analgesia use, and bladder catheterization. While the clinical effects of ambulation during labor remain controversial, there is a consensus on its positive impact on the birthing experience and satisfaction. Epidural analgesia remains the gold standard for pain control during labor, with a utilization rate of 82% in France. Recent advancements in obstetric analgesia have allowed for lower doses of analgesics, often administered via patient-controlled analgesia, which maintains the potential for ambulation during labor. However, only a small number of maternity units in France offer this technique. The main barriers include organizational issues such as unsuitable facilities, lack of wireless telemetry, and potential risks such as falls and hypotension. Significant changes in gait characteristics are observed throughout pregnancy, particularly during the third trimester, and are studied in laboratory settings using video capture and analysis. Gait during labor is influenced by pain, fetal progression, and anatomical changes in the pelvis. The presence of epidural analgesia, where local anesthetics likely affect neural transmission, may impact motor commands and sensory feedback, further altering gait characteristics. These biomechanical aspects of labor remain understudied. Wearable inertial sensors show promise in maternal health monitoring by providing real-time data for motion and gait studies. However, their application has not been described or validated during labor, particularly in walking conditions. Continuous dynamic study of gait in these conditions could enable non-invasive, non-intrusive monitoring of analgesia effectiveness, fall risk prediction, and labor progression analysis. The aim of this feasibility study is to validate the use of wearable inertial sensors to quantify movements and characterize gait during the first stage of labor, both with and without low-dose epidural analgesia.

Eligibility Criteria

Inclusion Criteria: * pregnancy \>= 38 gestation weeks * no significant medical history (American Society of Anesthesiologists class ASA 1) * receiving low-dose epidural analgesia with ambulation (in accordance with current service protocol) * not opposed to the study Exclusion Criteria: * Refusal to participate in this study * Non-French-speaking patient * History of osteoarticular pathology likely to change gate (severe scoliosis, spinal surgery, congenital hip deformity, pelvic fracture, ligament or knee joint pathology) * adults under legal protection * multiple pregnancy * need for continuous intravenous infusion with infusion stand during ambulation

Contact & Investigator

Central Contact

Mikhail DZIADZKO, MD

✉ mikhail.dziadzko@chu-lyon.fr

📞 04.26.10.93.25

Principal Investigator

Mikhail PH DZIADZKO, MD

PRINCIPAL INVESTIGATOR

Anesthésie Réanimation Douleur

Frequently Asked Questions

Who can join the NCT06471790 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Pregnancy Related. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06471790 currently recruiting?

Yes, NCT06471790 is actively recruiting participants. Contact the research team at mikhail.dziadzko@chu-lyon.fr for enrollment information.

Where is the NCT06471790 trial being conducted?

This trial is being conducted at Lyon, France.

Who is sponsoring the NCT06471790 clinical trial?

NCT06471790 is sponsored by Hospices Civils de Lyon. The principal investigator is Mikhail PH DZIADZKO, MD at Anesthésie Réanimation Douleur. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology